Effects of constituents of Amomum xanthioides on gastritis in rats and on growth of gastric cancer cells

Archives of Pharmacal Research

Volumn 30, Issue 4, 2007, Pages 436-443

  Yong, Soo Lee ^a   Min, Hee Kang ^a   So, Yean Cho ^b   Choon, Sik Jeong ^a  

^a Duksung Women's University   (South Korea)

^b Korea Food and Drug Administration   (South Korea)

Author keywords

Amomum xanthioides; Gastric cancer cell; Gastritis; Helicobacter pylori

Indexed keywords

EID: 34248143873     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02980217     Document Type: Article

References (23)

1. Asaka, M., Helicobacter pylori infection and gastric cancer. Intern. Med., 41, 1-6 (2002).
2. 2+-release channels. Trends Pharmacol. Sci., 15, 145-149 (1994).
3. George, V., Mathew, J., Sabulal, B., Dan, M., and Shiburaj, S., Chemical composition and antimicrobial activity of essential oil from the rhizomes of Amomum cannicarpum. Fitoterapia., 77, 392-394 (2006).
4. Gyires, K., Gastric mucosal protection: from prostaglandins to gene therapy. Curr. Med. Chem., 12, 203-215 (2005)
5. Kang, S. C., Lee, C. M., Choi, H., Lee. J. H., Oh, J. S., Kwak, J. H., and Zee, O. P., Evaluation of oriental medicinal herbs for estrogenic and antiproliferative activities. Phytother. Res., in press (2006).
6. Kim, S. H. and Shin, T. Y., Amomum xanthoides inhibits mast cell-mediated allergic reactions through the inhibition of histamine release and inflammatory cytokine production. Exp. Biol. Med., 230, 681-687 (2005).
7. Kinoshita, M., Noto, T., and Tamaki, H., Effect of a combination of ecabet sodium and cimetidine on experimentally induced gastric lesions and gastric mucosal resistance to ulcerogenic agents in rats. Biol. Pharm. Bull., 18, 223-226 (1995).
8. Kitajima, J. and Ishikawa, T., Water-soluble constituents of amomum seed. Chem. Pharm. Bull. (Tokyo), 51, 890-893 (2003).
9. Kusters, J. G., van Vliet, A. H., and Kuipers, E. J., Pathogenesis of Helicobacter pylori infection. Clin. Microbiol. Rev., 19, 449-490 (2006).
10. Matysiak-Budnik, T. and Megraud, F., Helicobacter pylori infection and gastric cancer. Eur. J. Cancer, 42, 708-716 (2006).
11. McConkey, D. J. and Orrenius, S., The role of calcium in the regulation of apoptosis. J. Leukoc. Biol., 59, 775-783 (1996).
12. McQuaid, K. R. and Isenberg, J. I., Medical therapy of peptic ulcer disease. Surg. Clin. North Am., 72, 285-316 (1992)
13. Mizui, T. and Dodeuchi, M., Effect of polyamines on acidified ethanol-induced gastric lesion in rats. Jpn. J. Pharmacol., 33, 939-945 (1983).
14. Naito, Y., Ito, M., Watanabe, T., and Suzuki, H., Biomarkers in patients with gastric inflammation: a systematic review. Digestion, 72, 164-180 (2005)
15. Nash, J., Lambert, L., and Deakin, M., Histamine H2-receptor antagonists in peptic ulcer disease. Evidence for a prophylactic use. Drugs, 47, 862-871 (1994).
16. Nostro, A., Cellini, L., Di Bartolomeo, S., Di Campli, E., Grande, R., Cannatelli, M. A., Marzio, L., and Alonzo, V., Antibacterial effect of plant extracts against Helicobacter pylori. Phytother. Res., 19, 198-202 (2005).
17. Park, B. H. and Park, J. W., The protective effect of Amomum xanthoides extract against alloxan-induced diabetes through the suppression of NFkappaB activation. Exp. Mol. Med., 33, 64-68 (2001).
18. Pisegna, J. R., Pharmacology of acid suppression in the hospital setting: focus on proton pump inhibition. Crit. Care Med., 30, S356-361 (2002)
19. Seiki, M., Ukei, S., Tanaka, Y., and Soeda, M., Studies of antiulcer effects of a new compound, zinc L-carnosine (Z-103). Nippon Yakurigaku Zasshi., 95, 257-269 (1990).
20. Shay, H., Komarov, S. A., Fels, S. S., and Meranze, D., A simple method for the uniform production of gastric ulceration in the rat. Gastroenterol., 4, 43-61 (1945).
21. van de Loosdrecht, A. A., Nennie, E., Ossenkoppele, G. J., Beelen, R. H., and Langenhuijsen, M. M., Cell mediated cytotoxicity against U 937 cells by human monocytes and macrophages in a modified colorimetric MTT assay. A methodological study. J. Immunol. Methods, 141, 15-22 (1991)
22. Welage, L. S., Pharmacologic properties of proton pump inhibitors. Pharmacotherapy, 23, 74S-80S (2003)
23. Woo, T. W., Chang, M. S., Chung, Y. K., Kim, K. B., Sohn, S. K., Kim, S. G., and Choi, W. S., Inhibitory action of YJA20379, a new proton pump inhibitor on Helicobacter pylori growth and urease. Arch. Pharm. Res., 21, 6-11 (1998).